Identification of cyclophilin A as a potential prognostic factor for clear-cell renal cell carcinoma by comparative proteomic analysis

被引:19
|
作者
Yang, Jin [3 ]
Li, Ang [2 ]
Yang, Yucong [1 ]
Li, Xu [1 ]
机构
[1] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Ctr Clin Mol Biol, Xian 710049, Peoples R China
[2] Xi An Jiao Tong Univ, Stomatol Hosp, Res Ctr Stomatol, Xian 710049, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian 710049, Peoples R China
基金
中国国家自然科学基金;
关键词
cyclophilin A; clear-cell renal cell carcinoma; proteomics; MALDI-TOF/MS; 2-DE; RLC-310; HK-2; PROTEIN EXPRESSION PROFILES; INTERFERON-ALPHA; 2-DIMENSIONAL ELECTROPHORESIS; INHIBITORY FACTOR; PROXIMAL TUBULE; ANNEXIN-II; PHASE-III; CANCER; LINE; SUNITINIB;
D O I
10.4161/cbt.11.5.14678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The high recurrence and improved survival rate of clear-cell renal cell carcinoma (ccRCC) demand for a continuous effort to search for novel prognostic factors. Here, a comparative proteomics approach based on two-dimensional polyacrylamide gel electrophoresis (2-DE) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was used to identify differentially expressed proteins between a ccRCC cell line RLC-310 and a normal renal cell line HK-2. Of the 31 proteins identified, Cyclophilin A (CypA) was a newly identified differentially expressed protein in ccRCC cell line. The overexpression of CypA in ccRCC tissues was confirmed using RT-PCR and western blot analyses. Further immunohistochemistry revealed that overexpression of CypA was associated with poor differentiation and decreased survival (p < 0.05, p < 0.0001). These data suggest that CypA may serve as a novel prognostic factor for ccRCC.
引用
收藏
页码:535 / 546
页数:12
相关论文
共 50 条
  • [21] Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma
    Roldan, Fiorella L.
    Izquierdo, Laura
    Ingelmo-Torres, Mercedes
    Lozano, Juan Jose
    Carrasco, Raquel
    Cunado, Alexandra
    Reig, Oscar
    Mengual, Lourdes
    Alcaraz, Antonio
    [J]. CANCERS, 2022, 14 (15)
  • [22] Molecular Genetics of Clear-Cell Renal Cell Carcinoma
    Brugarolas, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1968 - +
  • [23] The epigenetic landscape of clear-cell renal cell carcinoma
    Kluzek, Katarzyna
    Bluyssen, Hans A.
    Wesoly, Joanna
    [J]. JOURNAL OF KIDNEY CANCER AND VHL, 2015, 2 (03): : 90 - 104
  • [24] Expression of Aquaporin 1 in Primary Renal Tumors: A Prognostic Indicator for Clear-Cell Renal Cell Carcinoma
    Huang, Ying
    Murakami, Takayuki
    Sano, Futoshi
    Kondo, Keiichi
    Nakaigawa, Noboru
    Kishida, Takeshi
    Kubota, Toshinobu
    Nagashima, Yoji
    Yao, Masahiro
    [J]. EUROPEAN UROLOGY, 2009, 56 (04) : 690 - 698
  • [25] Metastatic clear-cell renal carcinoma to the parotid
    Lau, Steve Yee Chiang
    Chittleborough, Timothy John
    McCracken, James Albert
    Wijeratne, Shiran
    [J]. ANZ JOURNAL OF SURGERY, 2012, 82 (10) : 760 - 761
  • [26] Cholesterol and the development of clear-cell renal carcinoma
    Drabkin, Harry A.
    Gemmill, Robert M.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (06) : 742 - 750
  • [27] Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma
    Sonpavde, Guru
    Willey, Christopher D.
    Sudarshan, Sunil
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) : 305 - 315
  • [28] High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
    H An
    L Xu
    Y Zhu
    T Lv
    W Liu
    Y Liu
    H Liu
    L Chen
    J Xu
    Z Lin
    [J]. British Journal of Cancer, 2014, 110 : 2261 - 2268
  • [29] Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma
    Yao, M
    Tabuchi, H
    Nagashima, Y
    Baba, M
    Nakaigawa, N
    Ishiguro, H
    Hamada, K
    Inayama, Y
    Kishida, T
    Hattori, K
    Yamada-Okabe, H
    Kubota, Y
    [J]. JOURNAL OF PATHOLOGY, 2005, 205 (03): : 377 - 387
  • [30] High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
    An, H.
    Xu, L.
    Zhu, Y.
    Lv, T.
    Liu, W.
    Liu, Y.
    Liu, H.
    Chen, L. C
    Xu, J.
    Lin, Z.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2261 - 2268